Skip to main content
. 2020 Jan 24;12(2):1213–1236. doi: 10.18632/aging.102679

Figure 5.

Figure 5

miR-200a impaired anti-tumor immunity in vivo. (AB) Flow cytometry analysis of intratumoral proportion of CD4+ and CD8+ T cells. (CD) Flow cytometry analysis of intratumoral proportion of Foxp3+ Treg cells. (EF) Flow cytometry analysis of intratumoral proportion of IFN-γ+ CTLs. *P<0.05, **P<0.01, ***P<0.001.